PMHNP Scope of Practice for Narcolepsy in Texas

If you’re a psychiatrist or PMHNP treating narcolepsy patients — or considering adding narcolepsy to your telehealth practice — you’re navigating one of the most complex regulatory environments in medicine right now. Narcolepsy treatment typically requires Schedule II stimulants (Adderall, Ritalin), Schedule IV wakefulness agents (modafinil), and sometimes Schedule III medications like sodium oxybate. All controlled substances. All subject to federal DEA rules and a patchwork of state telehealth laws that can make or break your ability to prescribe remotely.

Here’s what you actually need to know about prescribing narcolepsy medications via telehealth in 2026 — the federal rules, the state-by-state variations, and how psychiatrists and PMHNPs differ in their prescriptive authority.

Federal DEA Rules: The Ryan Haight Act and Current Telehealth Flexibilities

The baseline federal law: The Ryan Haight Online Pharmacy Act (2008) normally requires at least one in-person medical evaluation before prescribing any controlled substance via telemedicine. That includes the stimulants and other controlled medications used for narcolepsy.

The reality right now: That requirement is temporarily waived through December 31, 2026. The DEA (with HHS) has extended COVID-era telehealth flexibilities multiple times, most recently in January 2026, allowing providers to prescribe controlled substances via telehealth without an initial in-person visit — as long as the prescription is legitimate and you comply with all other requirements (state licensure, DEA registration, standard of care).

This means as of February 2026, you can evaluate a narcolepsy patient via video, diagnose them, and prescribe methylphenidate or modafinil without ever meeting them in person — if your state law allows it (more on that below).

What’s coming: The DEA has been working on permanent telemedicine prescribing rules since 2022-2023. Initial proposals suggested requiring an in-person visit after an initial 30-day telemedicine prescription for Schedule II drugs, which triggered massive pushback — over 38,000 public comments. The agency shelved those rules and keeps extending the temporary flexibilities while reconsidering.

Most expect the final rules to be more flexible than the initial proposal, possibly carving out exceptions for established diagnoses like narcolepsy or ADHD with defined safeguards. The only permanent telemedicine rules finalized so far (January 2025) cover buprenorphine for opioid use disorder and VA continuity of care — suggesting the DEA is willing to create condition-specific pathways.

Bottom line for now: You have a stable regulatory window through 2026. Use it. But plan for the possibility that by 2027, you may need to arrange at least one in-person evaluation (or partner with local clinics) for new narcolepsy patients starting Schedule II medications.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State-by-State Reality: Where Telehealth Narcolepsy Prescribing Gets Complicated

Federal law sets the floor. States add their own rules. And some states have made telehealth prescribing of controlled substances — especially stimulants — significantly harder than others.

Florida: The Biggest Roadblock

Florida’s telehealth statute explicitly prohibits prescribing Schedule II controlled substances via telemedicine — with only four exceptions: treating a psychiatric disorder, inpatient hospital care, hospice, or nursing home patients.

Narcolepsy is not a psychiatric disorder. It’s a neurological sleep disorder. That means under Florida law, you cannot prescribe Adderall or other Schedule II stimulants for narcolepsy via pure telehealth, even though federal law currently allows it.

Workarounds:

• Prescribe modafinil (Schedule IV) instead — Florida’s ban only covers Schedule II and III
• Require at least one in-person visit with the patient in Florida before starting stimulants
• Partner with a Florida-based clinic that can handle the initial in-person exam

This isn’t theoretical — Florida enforces this. If you’re operating a telehealth platform serving Florida patients with narcolepsy, you need a compliance strategy.

Texas: NPs Can’t Prescribe Schedule II at All (Outpatient)

Texas allows telemedicine for psychiatrists with no special barriers (other than requiring two-way video for controlled substance prescriptions). But Texas APRNs cannot prescribe Schedule II controlled substances in outpatient settings — period.

The only exceptions are patients admitted to a hospital (24+ hour stay), emergency department visits, or terminally ill hospice patients — and even then, the prescription must be filled at the hospital or hospice pharmacy.

What this means:

• Texas PMHNPs can prescribe modafinil (Schedule IV) for narcolepsy with a physician delegation agreement
• They cannot prescribe Adderall, Ritalin, or other Schedule II stimulants for outpatient narcolepsy care
• Any Schedule II prescription must be written by a physician

If you’re a PMHNP planning to serve Texas patients with narcolepsy, you’ll need an overseeing physician willing to handle Schedule II prescriptions, or focus your practice on Schedule III-V medications.

New York: Aligned with Federal Rules (For Now)

New York formalized its telehealth controlled substance rules in May 2025. The state requires an in-person exam before prescribing controlled substances via telehealth — unless you’re complying with federal law.

Since federal law currently allows telehealth prescribing under the DEA waiver, New York psychiatrists and experienced PMHNPs (3,600+ hours) can prescribe narcolepsy medications remotely right now.

The catch: When the federal DEA waiver expires or changes, New York’s in-person requirement automatically kicks back in — unless you qualify for one of NY’s other exceptions (recent in-person exam by a consulting provider, covering for an established patient, etc.).

New York is a full-practice state for experienced PMHNPs, meaning they have the same prescriptive authority as physicians once they meet the experience threshold. Both can diagnose narcolepsy and prescribe all necessary medications independently.

California: NP Independence Expanding

California passed AB 890 creating a pathway for NPs to practice independently after 4,600+ hours of supervised practice. As of 2023, qualified NPs can obtain full practice authority, including prescribing Schedule II-V controlled substances on their own license.

California has no state-level telehealth restrictions beyond federal law. Both psychiatrists and independent NPs can prescribe narcolepsy medications via telehealth.

Requirements:

• NPs must complete specific pharmacology coursework on controlled substances (including addiction risk) before obtaining Schedule II authority
• All providers must check California’s CURES PDMP before prescribing Schedule II-IV medications (first time and at least every 4 months for ongoing therapy)
• Electronic prescribing is mandatory for controlled substances

Pennsylvania: CRNP Collaboration Required, But Telehealth Allowed

Pennsylvania is a restricted-practice state. CRNPs (Certified Registered Nurse Practitioners) must have a collaborative agreement with a physician to prescribe, including controlled substances.

CRNP limits:

• Maximum 30-day supply of Schedule II medications (physician consultation required for continuation)
• 90-day supply limit for Schedule III-IV

Pennsylvania has no specific prohibition on telehealth prescribing of controlled substances — it defers to federal rules. So both psychiatrists and CRNPs can prescribe narcolepsy medications via telehealth under the current DEA waiver.

The state requires two-way audio-visual communication (video) for telehealth evaluations when prescribing controlled substances.

Illinois: Full Practice Authority After 4,000 Hours

Illinois allows NPs to obtain Full Practice Authority (FPA) after 4,000 hours of collaborative practice plus 250 hours of continuing education. FPA-NPs can prescribe Schedule II-V independently.

Illinois has no state telehealth restrictions on controlled substances beyond federal law. Both psychiatrists and FPA-NPs can prescribe narcolepsy medications remotely.

Requirements:

• All NPs must obtain an Illinois Mid-Level Practitioner Controlled Substance License in addition to DEA registration
• Mandatory electronic prescribing for controlled substances (as of January 2023)
• Must check Illinois PMP before prescribing stimulants and other designated controlled substances

Psychiatrist vs PMHNP Scope: What You Can Actually Do

Psychiatrists (MD/DO):

Full prescriptive authority in all 50 states for any controlled substance within your DEA registration and state license. No special certification required to treat narcolepsy.

Practical considerations:

• You don’t need sleep medicine board certification, but you should be familiar with diagnostic criteria — most narcolepsy diagnoses require polysomnography and Multiple Sleep Latency Testing (MSLT)
• For telehealth, establish referral relationships with sleep centers in your patients’ states for diagnostic testing
• Some states (like Florida) explicitly list narcolepsy as a permissible indication for stimulant prescriptions in medical board rules — know your state’s language

PMHNPs:

Authority varies dramatically by state, especially for Schedule II medications.

Full or independent practice states (CA, NY, IL after meeting experience requirements):

• Can diagnose narcolepsy and prescribe all necessary medications independently
• Must still comply with collaborative requirements for certain high-risk medications in some states (e.g., Illinois requires physician consultation for benzodiazepines and opioids, but not stimulants)

Reduced/restricted practice states (FL, PA):

• Require physician collaboration agreements
• Florida limits Schedule II prescriptions to 7 days unless you’re a qualified ‘psychiatric nurse’ treating a mental health disorder (narcolepsy doesn’t qualify)
• Pennsylvania allows 30-day Schedule II prescriptions with physician oversight

Texas:

• Cannot prescribe Schedule II in outpatient settings at all
• Focus on Schedule III-V medications or work under physician supervision with MD writing Schedule II prescriptions

The Narcolepsy-Specific Challenges

Beyond general telehealth prescribing rules, treating narcolepsy remotely involves unique complications:

Diagnostic confirmation: Sleep studies (PSG and MSLT) typically require in-person testing at accredited sleep centers. You can order these remotely, but coordinating them adds operational complexity to a pure telehealth model.

Sodium oxybate (Xyrem/Xywav): Schedule III with an FDA-mandated REMS (Risk Evaluation and Mitigation Strategy) program. Prescribers must enroll in the program to prescribe or dispense. This adds administrative overhead but is manageable — just another system to set up.

State formulary rules: Some states explicitly list approved indications for stimulant prescriptions. Florida’s medical practice rules, for example, list narcolepsy as a legitimate use for Schedule II stimulants — meaning it’s explicitly allowed, not just not prohibited. Know your state’s language.

Patient acquisition cost reality: If you’re building a narcolepsy-focused telehealth practice, understand the economics. Acquiring a qualified psychiatric patient through DIY marketing (SEO, Google Ads, directories) realistically costs $200-500+ when you factor in:

• Agency/consultant fees
• Ad spend for testing and optimization (mental health keywords run $15-40+ per click)
• Staff time to qualify leads
• No-show rates from cold leads
• 6-12 months of SEO investment before meaningful results
• Failed campaigns

Psychology Today charges monthly fees and you’re competing with hundreds of providers on the same page. Zocdoc charges $35-100+ per booking plus monthly subscription fees.

The platform advantage: This is where a model like Klarity Health makes economic sense. Instead of spending $3,000-5,000/month on marketing with uncertain ROI, you pay a standard listing fee only when a pre-qualified patient books with you. No upfront marketing spend. No wasted ad dollars on clicks that don’t convert. Built-in telehealth infrastructure. Both insurance and cash-pay patient flow.

For narcolepsy specifically — a rare condition where patient acquisition is particularly expensive — removing marketing risk entirely lets you focus on what you do best: treating patients.

Compliance Essentials: What You Must Do

Regardless of state, if you’re prescribing controlled substances for narcolepsy via telehealth:

1. State PDMP checks: Nearly every state mandates checking the prescription drug monitoring program before prescribing controlled substances. Requirements vary (some require it every time, some allow periodic checks for established patients), but assume you need to check it.

2. Electronic prescribing: Most states now require e-prescribing for controlled substances. Paper prescriptions are being phased out. Your telehealth platform needs DEA-compliant e-prescribing (two-factor authentication, audit trails, etc.).

3. Documentation standards: Document your telehealth evaluation as thoroughly as an in-person visit. For narcolepsy:

• Detailed sleep history
• Epworth Sleepiness Scale or similar validated tools
• Mental status exam elements observable on video
• Justification for controlled medication choice and dose
• Plan for diagnostic confirmation (sleep study coordination)
• Emergency contact plan

4. Informed consent: Obtain specific consent for telehealth treatment, including acknowledgment of limitations (can’t perform physical exam, emergency protocols, etc.). Some states mandate this by regulation.

5. Risk management for controlled substances: Given abuse potential of stimulants, consider:

• More frequent initial follow-ups (weekly or biweekly for first month)
• Urine drug screening if clinically indicated
• Pill counts or pharmacy verification for high-risk patients
• Clear controlled substance agreements

These aren’t just compliance checkboxes — they’re malpractice risk management. Telehealth prescribing of controlled substances attracts scrutiny from medical boards and DEA. Document everything.

State-by-State Quick Reference

What to Do Now

If you’re a psychiatrist:

• Get licensed in states where you want to practice (consider IMLC for faster multi-state licensing — Illinois, Texas, Pennsylvania are members)
• Verify your DEA registration covers all states where you’ll see patients
• Set up PDMP access in each state
• Establish sleep study referral networks for diagnostic confirmation
• Plan for 2027 potential rule changes (hybrid models with local clinic partners)

If you’re a PMHNP:

• Understand your state’s scope limitations for Schedule II prescriptions
• In restricted states (Texas, Florida), either focus on Schedule III-V medications or work under physician oversight
• In full-practice states, ensure you meet experience requirements and have proper DEA/state controlled substance licenses
• Consider getting licensed in multiple full-practice states to maximize patient access

For both:

• Don’t gamble on DIY patient acquisition for a rare specialty like narcolepsy — the economics don’t work for most solo providers
• Platforms that handle patient acquisition and provide pre-qualified leads eliminate the $3,000-5,000/month marketing burn with uncertain results
• You control your schedule and only pay when you see patients — guaranteed ROI vs. gambling on marketing channels

Narcolepsy treatment is in desperate need of accessible providers. Telehealth removes geographic barriers, but only if you navigate the regulations correctly. The current federal flexibility through 2026 creates a window of opportunity — use it, but build your practice model to adapt when rules inevitably change.

Frequently Asked Questions

Can I prescribe Adderall for narcolepsy via telehealth right now?

Yes, under federal law through December 31, 2026 — unless your state prohibits it. Florida is the major exception, banning Schedule II telehealth prescriptions for non-psychiatric conditions. Texas allows it for MDs but not NPs. New York, California, Illinois, and Pennsylvania allow it under the current federal waiver.

What happens in 2027 when the DEA waiver expires?

Nobody knows for certain yet. The DEA is finalizing permanent rules, which may require an initial in-person visit for Schedule II medications, or impose 30-day supply limits before in-person follow-up. Plan for the possibility you’ll need hybrid models (partnering with local clinics for initial exams).

Can PMHNPs treat narcolepsy, or is that outside their scope?

Legally, yes — in states where they have prescriptive authority for the necessary medications. Practically, PMHNPs prescribe stimulants and other psychiatric medications routinely for ADHD, which overlaps significantly with narcolepsy pharmacotherapy. The key is staying within your competency — if a case is complex with neurological complications beyond your training, consult or refer.

Do I need sleep medicine certification to treat narcolepsy?

No legal requirement, but you should be clinically competent. Most narcolepsy diagnoses require polysomnography and MSLT confirmation. You don’t have to perform the sleep study yourself, but you should know when to order it and how to interpret results. Malpractice insurers may scrutinize whether treating narcolepsy falls within your documented expertise.

How do I handle the required sleep studies in a telehealth model?

Establish referral relationships with accredited sleep centers in the states where you practice. Order the studies remotely, coordinate scheduling with the patient, and review results via telehealth follow-up. Many sleep centers now send results electronically. It adds complexity but is manageable.

What’s the patient acquisition cost for a narcolepsy practice?

Realistically $200-500+ per qualified patient through traditional marketing channels when you account for all costs. Narcolepsy is rare — general mental health SEO or Google Ads won’t efficiently reach these patients. Directory listings put you in competition with hundreds of other providers. Platform models that pre-qualify and match patients eliminate this expense entirely.

Top 5 Citations

1. HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026’ (January 2, 2026) – www.hhs.gov

2. 21 U.S.C. §829(e) Ryan Haight Act – Legal definition of in-person medical evaluation and telemedicine exceptions (current through 2023 updates) – www.law.cornell.edu

3. Florida Statutes §456.47 – Use of Telehealth to Provide Services (prohibiting Schedule II telemedicine prescriptions except for psychiatric disorders) – www.leg.state.fl.us

4. New York State Department of Health – Controlled Substances Prescribing via Telehealth Final Rule (effective May 21, 2025) – www.nixonpeabody.com

5. Texas Medical Board – APRN Prescriptive Delegation FAQs (Schedule II facility-based restrictions) – www.tmb.state.tx.us

Source:

• https://www.law.cornell.edu/definitions/uscode.php?defid=21-USC-1796173870-113781527&height=800&iframe=true&termoccur=999&term_src=title%3A21%3Achapter%3A13%3Asubchapter%3AI%3Apart%3AC%3Asection%3A831&width=840#:~:text=,that%20a%20prescription%20has%20been
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,while%20permanent%20rules%20are%20finalized
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=promulgate%20a%20final%20set%20of,Medications%2C%E2%80%9D%20was%20submitted%20to%20the
• https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care#:~:text=On%20January%2017%2C%202025%2C%20DEA,to%20as%20the%20%E2%80%9CTwo%20Final
• https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499%2F0456%2FSections%2F0456.47.html#:~:text=telehealth%20to%20provide%20health%20care,in%20Schedule%20II%20of%20s
• https://www.tmb.state.tx.us/page/facility-based-prescriptive-delegation#:~:text=at%20the%20hospital%E2%80%99s%20facility,from%20a%20qualified%20hospice%20provider
• https://www.cchpca.org/resources/state-telehealth-laws-and-reimbursement-policies-report-fall-2025/#:~:text=Texas%20regulations%20emphasize%20continuity%20of,Note
• https://www.nixonpeabody.com/insights/alerts/2025/06/18/new-york-state-finalizes-telemedicine-rule-for-controlled-substances#:~:text=match%20at%20L114%20The%20rule,and%20the%20US%20Department%20of
• https://www.nixonpeabody.com/insights/alerts/2025/06/18/new-york-state-finalizes-telemedicine-rule-for-controlled-substances#:~:text=In%20short%2C%20the%20exception%20permits,as%20a%20condition%20of%20state
• https://rxagent.co/blog/np-prescribing-authority#:~:text=Conversely%2C%20in%20Restricted%20Practice%20states,expand%20this%20scope%20%206